Αρχειοθήκη ιστολογίου

Πέμπτη 7 Δεκεμβρίου 2017

Revisiting NICE's approval of 'breakthrough' drugs palbociclib and ribociclib

Claims of cancer drugs ' survival benefits must be accurate. To avoid fashion and fads, we must carefully examine the clinical and economic implications of newly approved cancer drugs before we seat them on the 'breakthrough' throne. (Source: Clinical Pharmacist)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2j2g73Q
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader